Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Lineage Cell Therapeutics, Inc. | 900,000 | reported | 05 Mar 2026 | tx 22+4,360,341−34,278 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 05 Mar 2026 | GRANT_AWARD | Lineage Cell Therapeutics, Inc. | 900,000 | 0.00 USD | deriv |
| 11 Feb 2026 | EXERCISE | Lineage Cell Therapeutics, Inc. | 6,075 | — | |
| 11 Feb 2026 | TAX_WITHHOLDING | Lineage Cell Therapeutics, Inc. | 2,502 | 1.80 USD | |
| 11 Feb 2026 | EXERCISE | Lineage Cell Therapeutics, Inc. | 6,075 | 0.00 USD | deriv |
| 19 Dec 2025 | GRANT_AWARD | Lineage Cell Therapeutics, Inc. | 1,735 | — | |
| 19 Dec 2025 | TAX_WITHHOLDING | Lineage Cell Therapeutics, Inc. | 65 | 1.68 USD | |
| 10 Mar 2025 | GRANT_AWARD | Lineage Cell Therapeutics, Inc. | 750,000 | 0.00 USD | deriv |
| 11 Feb 2025 | EXERCISE | Lineage Cell Therapeutics, Inc. | 6,076 | — | |
| 11 Feb 2025 | TAX_WITHHOLDING | Lineage Cell Therapeutics, Inc. | 2,440 | 0.65 USD | |
| 11 Feb 2025 | EXERCISE | Lineage Cell Therapeutics, Inc. | 6,076 | 0.00 USD | deriv |
| 26 Nov 2024 | PURCHASE | Lineage Cell Therapeutics, Inc. | 15,000 | 0.60 USD | |
| 07 Mar 2024 | GRANT_AWARD | Lineage Cell Therapeutics, Inc. | 650,000 | 0.00 USD | deriv |
| 11 Feb 2024 | EXERCISE | Lineage Cell Therapeutics, Inc. | 6,076 | — | |
| 11 Feb 2024 | TAX_WITHHOLDING | Lineage Cell Therapeutics, Inc. | 2,490 | 1.08 USD | |
| 11 Feb 2024 | EXERCISE | Lineage Cell Therapeutics, Inc. | 6,076 | 0.00 USD | deriv |
| 09 Mar 2023 | GRANT_AWARD | Lineage Cell Therapeutics, Inc. | 650,000 | 0.00 USD | deriv |
| 11 Feb 2023 | EXERCISE | Lineage Cell Therapeutics, Inc. | 6,076 | — | |
| 11 Feb 2023 | TAX_WITHHOLDING | Lineage Cell Therapeutics, Inc. | 2,478 | 1.35 USD | |
| 11 Feb 2023 | EXERCISE | Lineage Cell Therapeutics, Inc. | 6,076 | 0.00 USD | deriv |
| 10 Mar 2022 | GRANT_AWARD | Lineage Cell Therapeutics, Inc. | 650,000 | 0.00 USD | deriv |
| 11 Feb 2022 | GRANT_AWARD | Lineage Cell Therapeutics, Inc. | 24,303 | 0.00 USD | deriv |
| 01 Sept 2021 | GRANT_AWARD | Lineage Cell Therapeutics, Inc. | 695,000 | 0.00 USD | deriv |